0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cancer Biomarkers
 21-40 of 203 Articles
JAMA Surgery | 
Surgical Innovation | 
Zaynab Jawad, MSc, MRCS; Fang Xie, PhD; Long R. Jiao, MD, FRCS
JAMA Surg. 2015;150(12):1184-1185. doi:10.1001/jamasurg.2015.2654.

JAMA Dermatology | 
Original Investigation |  ONLINE FIRST
Rui Xu, BS; Mu-Yan Cai, MD; Rong-Zhen Luo, MD; et al.
JAMA Dermatol. Published online November 11, 2015. doi:10.1001/jamadermatol.2015.3781

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
William N. William Jr, MD; Vassiliki Papadimitrakopoulou, MD; J. Jack Lee, PhD; et al.
JAMA Oncol. Published online November 05, 2015. doi:10.1001/jamaoncol.2015.4364
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Mark M. Moasser, MD; Ian E. Krop, MD, PhD
JAMA Oncol. 2015;1(8):1154-1161. doi:10.1001/jamaoncol.2015.2286.

JAMA Oncology | 
Editorial | 
Wendy Y. Chen, MD, MPH
JAMA Oncol. 2015;1(8):1037-1038. doi:10.1001/jamaoncol.2015.3286.

JAMA Oncology | 
From The JAMA Network |  FREE
Mouhab Ayas, MD
JAMA Oncol. 2015;1(8):1164-1165. doi:10.1001/jamaoncol.2015.0992.

JAMA Oncology | 
Review |  FREE
Chadi Nabhan, MD; Gordana Raca, MD, PhD; Y. Lynn Wang, MD, PhD
JAMA Oncol. 2015;1(7):965-974. doi:10.1001/jamaoncol.2015.0779.

JAMA | 
Viewpoint | 
Steven J. Katz, MD, MPH; Allison W. Kurian, MD, MSc; Monica Morrow, MD
JAMA. 2015;314(10):997-998. doi:10.1001/jama.2015.8088.

JAMA Ophthalmology | 
Original Investigation | 
Gaia Barisione, MSc; Marina Fabbi, MD, PhD; Alice Gino, MSc; et al.
JAMA Ophthalmol. 2015;133(9):1013-1021. doi:10.1001/jamaophthalmol.2015.1766.

JAMA Neurology | 
Original Investigation | 
Helena Ariño, MD; Romana Höftberger, MD; Nuria Gresa-Arribas, PhD; et al.
JAMA Neurol. 2015;72(8):874-881. doi:10.1001/jamaneurol.2015.0749.
Includes: Supplemental Content

JAMA Surgery | 
Invited Commentary | 
Julie A. Margenthaler, MD; Aislinn Vaughan, MD
JAMA Surg. 2015;150(8):746. doi:10.1001/jamasurg.2015.0895.

JAMA Surgery | 
Original Investigation | 
Georgios Antonios Margonis, MD; Yuhree Kim, MD, MPH; Gaya Spolverato, MD; et al.
JAMA Surg. 2015;150(8):722-729. doi:10.1001/jamasurg.2015.0313.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Mary-Ellen Taplin, MD; Steven P. Balk, MD, PhD
JAMA Oncol. 2015;1(5):577-579. doi:10.1001/jamaoncol.2015.1457.

JAMA Oncology | 
Original Investigation | 
Emmanuel S. Antonarakis, MD; Changxue Lu, PhD; Brandon Luber, ScM; et al.
JAMA Oncol. 2015;1(5):582-591. doi:10.1001/jamaoncol.2015.1341.
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint |  FREE
Michael D. Farwell, MD; Amy S. Clark, MD, MSCE; David A. Mankoff, MD, PhD
JAMA Oncol. 2015;1(4):421-422. doi:10.1001/jamaoncol.2015.0667.

JAMA Ophthalmology | 
Original Investigation | 
Ana V. Torbidoni, PhD; Viviana E. Laurent, MSc; Claudia Sampor, MD; et al.
JAMA Ophthalmol. 2015;133(7):805-812. doi:10.1001/jamaophthalmol.2015.0900.

JAMA Oncology | 
Original Investigation |  FREE
Roberto Salgado, MD, PhD; Carsten Denkert, MD, PhD; Christine Campbell, MSc; et al.
JAMA Oncol. 2015;1(4):448-455. doi:10.1001/jamaoncol.2015.0830.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  FREE
Himisha Beltran, MD; Kenneth Eng, MS; Juan Miguel Mosquera, MD; et al.
JAMA Oncol. 2015;1(4):466-474. doi:10.1001/jamaoncol.2015.1313.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  FREE
Nancy E. Thomas, MD, PhD; Sharon N. Edmiston, BS; Audrey Alexander, BS; et al.
JAMA Oncol. 2015;1(3):359-368. doi:10.1001/jamaoncol.2015.0493.
Includes: Supplemental Content

JAMA Oncology | 
Review |  FREE
Douglas B. Johnson, MD, MSCI; Jeffrey A. Sosman, MD
JAMA Oncol. 2015;1(3):380-386. doi:10.1001/jamaoncol.2015.0565.
Includes: CME

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Microsatellite Instability and BRAF and KRAS Mutations in Stage III Colon Cancer Requirements for Accurate Prognosis Assessment
Dirk Klingbiel, PhD; Sabine Tejpar, MD, PhD
JAMA Oncology
Original Investigation  | 
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab A Post Hoc Analysis of the PETACC-8 Trial
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.
JAMA Dermatology
Brief Report  | 
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
Mina S. Ally, MD; Katherine Ransohoff, BA; Kavita Sarin, MD, PhD; et al.
JAMA Oncology
Invited Commentary  | 
DNA Damage and Repair Pathway Profiles as Biomarkers in High-Risk Prostate Cancer
Sean E. McGuire, MD, PhD